Gulf markets rise as Iran plays down Israel's strikes By Reuters
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 27 2024
0mins
Source: Investing.com
Gulf Stock Market Performance: Most Gulf stock markets rose on Sunday, with Saudi Arabia's index up 1.5% and Qatar's index also gaining 1.5%, as tensions between Israel and Iran eased following limited damage from Israeli airstrikes.
Crude Prices and Diplomatic Talks: Analysts expect crude prices to fall due to the lack of disruption in Iranian oil infrastructure, while U.S. and Israeli intelligence officials met in Qatar to negotiate a potential ceasefire deal for Gaza.
Analyst Views on QSI
Wall Street analysts forecast QSI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QSI is 2.67 USD with a low forecast of 1.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.310
Low
1.50
Averages
2.67
High
4.00
Current: 1.310
Low
1.50
Averages
2.67
High
4.00
About QSI
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








